NTEC News and Press, Intec Pharma Ltd. From 10/29/20

Intec Pharma Announces 1-for-20 Reverse Share Split PR Newswire JERUSALEM, Oct. 29, 2020 JERUSALEM , Oct. 29, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces a 1-for-20 reverse share split of its outstanding or...

Are These 4 Pre Market Penny Stocks On Your Watch List Today? There’s no shortage of news when it comes to penny stocks . But sometimes it takes a minute to find the true source of momentum. In many cases, you’ll have to read between the lines and think outside...

Intec Pharma (NTEC) +13% premarket after announcing a new research collaboration agreement with MSD, the tradename of Merck & Co, USA.The details of the agreement are not disclosed."This new agreement builds upon the relationship we have enjoyed in prior research and allows the ...

Intec Pharma Announces New Research Collaboration Agreement with MSD PR Newswire JERUSALEM, Oct. 8, 2020 JERUSALEM , Oct. 8, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces it has entered into a new research co...

Virios Therapeutics has filed to raise $30 million in an IPO of its common stock. The firm is developing a proprietary formulation for the treatment of fibromyalgia, a pain condition. VIRI has achieved intriguing early efficacy results, received fast track review status and the IP...

Quick Take Virios Therapeutics ( VIRI ) has filed to raise $34.5 million in an IPO of its common stock, according to an S-1 registration statement . The company is developing a drug treatment for fibromyalgia, a nerve pain condition. VIRI has generated interesting early stage efficacy r...

JERUSALEM , Sept. 14, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. Oppenheimer Fall Healthcare Life Sciences & ...

JERUSALEM , Sept. 8, 2020 /PRNewswire/ --   Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the virtual H.C. Wainwright 22 nd Annual Global Investment Conference. H.C. Wainwright 22 nd Annual Global Investmen...

Through a registered direct offering, Intec Pharma (NASDAQ: NTEC )   -9.2%  PM,  entered into a definitive agreement with Aspire Capital Fund for the purchase and sale of 7.13M of shares at $0.3511/share, and pre-funded warrants to purchase 7.13M of shares at $0.3411/warrant...

JERUSALEM, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”), today announced that it has entered into a definitive agreement with Aspire Capital Fund (“Aspire”) for the purchase and sale, in a registere...